278 related articles for article (PubMed ID: 20879984)
1. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
2. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Cancer Res; 2009 Oct; 69(20):7953-9. PubMed ID: 19808959
[TBL] [Abstract][Full Text] [Related]
3. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
[TBL] [Abstract][Full Text] [Related]
4. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
5. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-like cancer cells in cancer cell lines.
Kondo T
Cancer Biomark; 2007; 3(4-5):245-50. PubMed ID: 17917153
[TBL] [Abstract][Full Text] [Related]
7. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
[TBL] [Abstract][Full Text] [Related]
8. Selective calcium sensitivity in immature glioma cancer stem cells.
Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
[TBL] [Abstract][Full Text] [Related]
9. NKX2.2 suppresses self-renewal of glioma-initiating cells.
Muraguchi T; Tanaka S; Yamada D; Tamase A; Nakada M; Nakamura H; Hoshii T; Ooshio T; Tadokoro Y; Naka K; Ino Y; Todo T; Kuratsu J; Saya H; Hamada J; Hirao A
Cancer Res; 2011 Feb; 71(3):1135-45. PubMed ID: 21169405
[TBL] [Abstract][Full Text] [Related]
10. Brain cancer stem-like cells.
Kondo T
Eur J Cancer; 2006 Jun; 42(9):1237-42. PubMed ID: 16632342
[TBL] [Abstract][Full Text] [Related]
11. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
12. Essential role of the Hedgehog signaling pathway in human glioma-initiating cells.
Takezaki T; Hide T; Takanaga H; Nakamura H; Kuratsu J; Kondo T
Cancer Sci; 2011 Jul; 102(7):1306-12. PubMed ID: 21453386
[TBL] [Abstract][Full Text] [Related]
13. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
14. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells.
Kurtsdotter I; Topcic D; Karlén A; Singla B; Hagey DW; Bergsland M; Siesjö P; Nistér M; Carlson JW; Lefebvre V; Persson O; Holmberg J; Muhr J
Cancer Res; 2017 Sep; 77(18):4985-4997. PubMed ID: 28687615
[TBL] [Abstract][Full Text] [Related]
15. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
[TBL] [Abstract][Full Text] [Related]
16. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells are enriched in the side population cells in a mouse model of glioma.
Harris MA; Yang H; Low BE; Mukherjee J; Guha A; Bronson RT; Shultz LD; Israel MA; Yun K
Cancer Res; 2008 Dec; 68(24):10051-9. PubMed ID: 19074870
[TBL] [Abstract][Full Text] [Related]
18. Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.
Clément-Schatlo V; Marino D; Burkhardt K; Teta P; Leyvraz F; Schatlo B; Frank S; Schaller K; Castella V; Radovanovic I
Neuro Oncol; 2012 Jun; 14(6):720-35. PubMed ID: 22584872
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging, tracking, and targeting of cancer stem cells.
Vlashi E; Kim K; Lagadec C; Donna LD; McDonald JT; Eghbali M; Sayre JW; Stefani E; McBride W; Pajonk F
J Natl Cancer Inst; 2009 Mar; 101(5):350-9. PubMed ID: 19244169
[TBL] [Abstract][Full Text] [Related]
20. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
